Partnership combines Lunit's platform-agnostic AI pathology algorithms with CellCarta's global CDx development and laboratory execution to help biopharma teams de-risk assets and accelerate evidence ...
Deciding whether to administer chemotherapy after surgery is one of the most challenging questions in early-stage breast ...
The funding will help transition the company’s AI lymphoma diagnostic into clinical use, with initial deployments in NHS ...
Craig Griffeth, 74, has always worried about cancer. “My aunts and uncles, almost all of them on both sides, died of cancer,” he said. “So, I figured that one day I’m going to get cancer, and I’ll ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results